October 30th 2024
Bob Rhatigan, CEO of Merz Aesthetics, discusses the organization’s commitment to advancing the aesthetics industry through strategic partnerships, specialized training, and a growing portfolio of injectables and devices.
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Dermalorian™ Webinar Series on Moderate to Severe Atopic Dermatitis
November 21, 2024 - December 5, 2024
View More
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Patients still having too much
June 1st 2002For more than a decade and a half, dermatologists have been stronglyadvocating the use of sunscreens and urging people to avoid sun exposure- yet skin cancer is still the most common cancer in the United States.It affects about a million Americans every year and is responsible for about2 percent of all cancer deaths, with melanoma accounting for about three-quartersof all skin cancer deaths.
Tanning beds, acitretin equal psoriasis clearing
June 1st 2002New Orleans - A small study combining commercial tanning bed therapy and acitretin has provided big results for patients with moderate to severe plaque-type psoriasis. In addition to rapid clearance of skin disease, the treatment is far more accessible for most patients and much less expensive than more traditional forms of light therapy,
Helpful hints for hard-to-heal wounds
May 1st 2002New Orleans - Chronic wound healing can be enhanced through a variety of products that encompass systemic agents such as pentoxifylline and aspirin to tissue-engineered skin and growth factors that stimulate healing, according to Robert S. Kirsner, MD.
Adjunctive approaches aid in acute wound healing
May 1st 2002New Orleans - Adjunctive therapies from occlusive dressings to growth factors and tissue-engineered skin can hasten and augment the healing of acute wounds, Robert S. Kirsner, M.D., said at the annual meeting of the American Academy of Dermatology.
Stringent efforts in Japan fail to boost sunscreen knowledge
May 1st 2002New Orleans - In a study of sun exposure and sunscreen use, fewmedical and nursing students in Japan understood SPF (sun protection factor)or PA (UVA protection grade), although most of the students used sunscreento prevent sunburn.
Sclerotherapy: Not just for leg veins anymore
May 1st 2002New Orleans - The benefits of sclerotherapy are not limited to varicose and spider veins of the legs. Dilated reticulated facial veins and prominent veins in the hands are also amenable to sclerotherapy, according to speakers at the annual meeting of the American Academy of Dermatology.
Play Botox!: Drug improves lateral browlift
May 1st 2002New Orleans - Lateral browlift is an additional benefit of botulinum toxin type A (Botox) treatment for glabellar rhytids, according to a quantitative analysis reported by Alastair Carruthers, M.D., at the annual meeting of the American Academy of Dermatology.